Key result
Contralaterally referenced ear-EEG channels detected hypoglycemia with an average sensitivity of ≥90% and specificity of ≥82%, showing no statistical difference compared to scalp EEG.
Why the study?
Scalp EEG can detect characteristic hypoglycemia-induced changes but is obtrusive and unsuitable for continuous real-life monitoring, motivating the evaluation of discreet dry-contact in-ear electrodes.
Does ear-EEG accurately detect hypoglycemia-induced episodes compared to scalp EEG in patients with Type 1 diabetes?
Observational (n=5)
No
Does ear-EEG accurately detect hypoglycemia-induced episodes compared to scalp EEG in patients with Type 1 diabetes?
Ear-EEG with contralaterally referenced channels can detect hypoglycemia with high sensitivity and specificity, offering a potential wearable solution for continuous monitoring in Type 1 diabetes.
Answers are grounded in this paper and cite their sources.
Ear-EEG may enable wearable hypoglycemia detection in T1D; leaves open validation in larger prospective studies.
Background: Hypoglycemia refers to the condition in which the blood glucose is severely below normal level. Hypoglycemia can cause difficulties to talk, headache, irritability, anxiety, confusion, convulsions, seizures, unconsciousness, and even death. These symptoms are a consequence of insufficient supply of glucose to the brain. It has previously been demonstrated that hypoglycemia results in characteristic changes in the electroencephalographic (EEG) signals recorded from electrodes on the scalp. Scalp EEG is not suitable for continuous measurements, due to its obtrusive nature and limited capabilities for monitoring in real-life environments. The objective of this study was to asses the feasibility of detecting hypoglycemia-induced episodes using EEG signals recorded with dry-contact in-ear electrodes, which are discreet, have the potential for long-term EEG monitoring in real-life situations, and provide similar information to that recorded with scalp EEG. The data from 5 diabetic subjects were used for this study. Six ear-EEG channels recorded from dry-contact iridium oxide electrodes fitted the right ear, and channels C3, Pz, T7, and T8 were used for the analysis and classification procedures. A Support Vector Machine (SVM) with a linear kernel was used to detect the hypoglycemic episodes, using a normalized measure of the total power of the θ,α,β, and γ frequency bands as features. Results: The results showed that there were no statistical differences between the sensitivity and specificity of the contralaterally referenced scalp-scalp and ear-scalp EEG channels. Contralaterally referenced channels showed an average sensitivity over all 5 subjects ≥90%, SD≤10% and an average specificity over all 5 subjects ≥82%, SD≤24%. The sensitivities and specificities obtained with the data from the ipsilaterally referenced ear-ear EEG channels did not exceed chance level. Trial registration: ClinicalTrials.gov NCT03022058. Registered 13 December 2016 https://clinicaltrials.gov/ct2/show/NCT03022058?term=uneeg&draw=3&rank=12.
No takes yet. Share an insight, caveat, or question.
Cabrera et al. (2020) conducted an observational in Type 1 diabetes (n=5). ear-EEG (dry-contact in-ear electrodes) vs. Scalp EEG was evaluated on Sensitivity and specificity of hypoglycemia detection. Contralaterally referenced ear-EEG channels detected hypoglycemia with an average sensitivity of ≥90% and specificity of ≥82%, showing no statistical difference compared to scalp EEG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: